Baxter Executive and Leadership Team

Anita Zielinski, the Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer & Controller at Baxter, manages the entire financial architecture of the organization. Zielinski directs global accounting practices, ensures rigorous regulatory compliance, and maintains the integrity of financial reporting systems. By overseeing capital allocation and fiscal planning, the Chief Financial Officer supports the development of medical devices and pharmaceuticals. This leadership role involves constant collaboration with the Board to optimize balance sheets and drive long-term shareholder value. Through precise management of corporate controllership, Anita Zielinski secures the financial stability necessary for ongoing research and development. The Chief Financial Officer also monitors global market trends to mitigate economic risks, ensuring that Baxter maintains a competitive edge in the healthcare manufacturing sector while upholding the highest standards of fiscal transparency and operational excellence.

Stacey Eisen, the Senior Vice President, Chief Communications Officer and Corporate Marketing. President, Baxter International Foundation at Baxter, architects the global brand strategy and corporate narrative. Eisen directs internal and external communications, ensuring alignment between the company mission and public perception. By managing corporate marketing initiatives, the Chief Communications Officer amplifies the impact of medical technologies and hospital care products. This leadership role involves guiding the Baxter International Foundation to foster community health and social responsibility. Through strategic engagement with stakeholders, Stacey Eisen strengthens the reputation of the organization across diverse healthcare markets. The Chief Communications Officer also coordinates with executive leadership to articulate the value of injectable therapies and surgical technologies. Ultimately, Eisen drives brand equity and social impact, ensuring that the global presence of the company reflects a commitment to patient care and innovation.

Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, oversees the development and manufacturing of critical infusion systems and injectable therapies. Soriano directs the product lifecycle for these essential hospital care solutions, ensuring that clinical providers receive high-quality medical devices. By managing the infusion technologies portfolio, the Group President drives innovation in patient monitoring and therapeutic delivery. This leadership role involves coordinating with research teams to advance pharmaceutical offerings that address complex medical needs. Through operational oversight of manufacturing processes, Cecilia Soriano ensures that the company maintains a robust supply chain for hospitals and clinics worldwide. The Group President also evaluates market demand to prioritize product enhancements that improve patient safety. Ultimately, Soriano optimizes the delivery of life-sustaining therapies, reinforcing the position of the company as a leader in the global healthcare manufacturing landscape.

Andrew Frye, the Senior Vice President & President (APAC) at Baxter, directs all commercial operations and strategic growth initiatives across the Asia-Pacific region. Frye oversees the distribution of medical devices and hospital care products, tailoring market strategies to meet the unique regulatory and clinical requirements of diverse APAC nations. By managing regional teams, the Senior Vice President & President (APAC) ensures that infusion systems and surgical technologies reach healthcare providers efficiently. This leadership role involves building partnerships with local clinics and hospitals to expand the footprint of the company. Through the execution of regional business plans, Andrew Frye drives revenue growth and operational efficiency in a high-demand market. The Senior Vice President & President (APAC) also monitors regional healthcare trends to inform global product development. Ultimately, Frye secures the market position of the company by delivering essential medical solutions to patients throughout the Asia-Pacific territory.